Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?

Authors

• Fabio Vieira Teixeira Clinica Gastrosaude, Marilia, SP https://orcid.org/0000-0002-8915-7279
• Rogerio Serafim Parra Universidade de Sao Paulo, Faculdade de Medicina de Ribeirao Preto https://orcid.org/0000-0002-5566-9284
• Omar Feres Universidade de Sao Paulo, Faculdade de Medicina de Ribeirao Preto https://orcid.org/0000-0003-3593-0526
• Paulo Gustavo Kotze Universidade Catolica do Parana https://orcid.org/0000-0002-9632-6691